Management

Pontus Nobréus

Chief Executive Officer Pontus Nobréus has extensive international experience as a CEO and commercial leader within MedTech, Life Science and the pharmaceutical industry. He has previously served as CEO of Redsense Medical, Pro Health Pharma Sweden and Glycorex Transplantation, and has held senior international positions in business development and sales. Pontus also has board experience within digital health. He holds an MBA from Henley Business School and an M.Sc. in Mechanical Engineering from Lund University.

Manoush Masarrat

Chief Operation Officer Manoush Masarrat has extensive Executive and Management experience in the Medical Technology industry. His career has included several strategic C-suite roles in Sales and Marketing, his area of outstanding expertise. Mr Masarrat has a BSc. in Industrial Economics from Gävle University (Sweden) and MSc. Courses in International Business Management from Macquarie University in Sydney, Australia.
Per Gerde

Per Gerde

Chief Scientific Officer, Associate Professor of Inhalation Toxicology, Scientist at the Division of Physiology, Institute of Environmental Medicine at the Karolinska Institutet. Previous appointments include scientist at the Lovelace Respiratory Research Institute (1993– 1998), scientist at the Swedish National Institute of Occupational Health (1991–1996), and postdoctoral fellow at the Lovelace Respiratory Research Institute (1989–1991). Dr. Gerde has published approx. 30 peer reviewed scientific papers. He is also the main inventor of six patent families with related patent applications.

Ulf Wedenberg

Chief Commercial Officer Ulf Wedenberg has over 25 years of experience from leading roles in sales, marketing and business development in the pharmaceutical and medical device sector. He has previously held key positions in companies such as Mölnlycke Healthcare, Nycomed and SHL Healthcare, where he built and led international commercial organizations with a focus on profitable growth and long-term market establishment.